APA (7th ed.) Citation
(2026). Teprotumumab-associated persistent unilateral hearing loss in dysthyroid optic neuropathy: A case report with review of the literature. Endocrine Journal.
Chicago Style (17th ed.) Citation
"Teprotumumab-associated Persistent Unilateral Hearing Loss in Dysthyroid Optic Neuropathy: A Case Report with Review of the Literature." Endocrine Journal 2026.
MLA (9th ed.) Citation
"Teprotumumab-associated Persistent Unilateral Hearing Loss in Dysthyroid Optic Neuropathy: A Case Report with Review of the Literature." Endocrine Journal, 2026.
Warning: These citations may not always be 100% accurate.